FolioLanternBeta
MPLTMapLight Therapeutics, Inc.

Kristopher Hanson

General Counsel at MapLight Therapeutics, Inc., as of Sep 18, 2026Sold $1.7M of stock in the past 12 months: 60% under a disclosed plan and 40% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
137K
shares held after the latest filing, MapLight Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
63K
shares sold, past 12 months
8
days with sales
$419K
largest single day, May 11, 2026
1
company filed for

Share of stake sold at MapLight Therapeutics, Inc. is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarApr 2026: $49K to cover taxesAprMay 2026: $807K under a disclosed plan$807KMayJunJul 2026: $608K to cover taxesJulAugSep 2026: $193K under a disclosed planSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
MapLight Therapeutics, Inc. (MPLT)General CounselOct 27, 2025Sep 18, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.